Patents by Inventor Michael Hawley

Michael Hawley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11989182
    Abstract: A data analysis system for measuring a materiality feature of interest is disclosed. The system includes a computing cluster ingesting content comprising a plurality of observables relevant to an entity, wherein each observable is related to at least one feature of interest. The system further includes an extraction engine running on the computing cluster and tagging the observables with an entity identifier in response to the observables referencing at least one of an entity, a tradename associated with the entity, or product associated with the entity. Additionally, the system includes an analysis engine running on the computing cluster and tagging an observable in response to the feature of interest being related to the observable. In one embedment, the analysis engine measures the materiality of the feature of interest to the entity by counting a number of observables from the plurality of observables tagged with the entity identifier.
    Type: Grant
    Filed: January 12, 2021
    Date of Patent: May 21, 2024
    Assignee: TruValue Labs, INC.
    Inventors: Greg Paul Bala, Michael Alfred Flowers, Adam L. Salvatori, Sebastian Brinkmann, Stephen Malinak, Eli Reisman, Andrew Shipley, Mark Strehlow, Hendrik Bartel, Philip Kim, James Hawley, Edwin Kuh
  • Patent number: 11975294
    Abstract: A conditioning system for a filter module is disclosed. The conditioning system may generally include an inlet, a heat exchanger, a magnetically levitated pump, a channel provided to bypass the heat exchanger, a controller, an outlet, and a base. The system may have components lined with corrosion-resistant materials. A method of conditioning a filter module is also disclosed. The method may generally include measuring TOC in a source of ultrapure water, heating the ultrapure water, rinsing a filter module with the heated water, flushing the filter module with ambient temperature water, and repeating the rinsing with heated water and flushing with ambient temperature water. A method of facilitating conditioning of the filter module is also disclosed. The method may generally include providing a portable filter module conditioning system and providing instructions for installation or use.
    Type: Grant
    Filed: December 20, 2018
    Date of Patent: May 7, 2024
    Assignee: Evoqua Water Technologies LLC
    Inventors: Michael Gullion, Christopher Hall, Joshua Hawley
  • Patent number: 9290479
    Abstract: The present invention relates to solid salt forms of the 3-pyrrole substituted 2-indolinone compound 5-[5-fluoro-2-oxo-1,2-dihydro-indol-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-pirrolidin-1-yl-ethyl)-amide. It also relates to polymorphs of the phosphate salt of the amide. The invention further relates to the use of the salts and polymorphs in the treatment of protein kinase related disorders.
    Type: Grant
    Filed: February 12, 2015
    Date of Patent: March 22, 2016
    Assignee: Zoetis Services LLC
    Inventors: Michael Hawley, Changquan Calvin Sun
  • Publication number: 20150158849
    Abstract: The present invention relates to solid salt forms of the 3-pyrrole substituted 2-indolinone compound 5-[5-fluoro-2-oxo-1,2-dihydro-indol-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-pirrolidin-1-yl-ethyl)-amide. It also relates to polymorphs of the phosphate salt of the amide. The invention further relates to the use of the salts and polymorphs in the treatment of protein kinase related disorders.
    Type: Application
    Filed: February 12, 2015
    Publication date: June 11, 2015
    Inventors: Michael Hawley, Changquan Calvin Sun
  • Patent number: 8987320
    Abstract: The present invention relates to solid salt forms of the 3-pyrrole substituted 2-indolinone compound 5-[5-fluoro-2-oxo-1, 2-dihydro-indol-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-pirrolidin-1-yl-ethyl)-amide. It also relates to polymorphs of the phosphate salt of the amide. The invention further relates to the use of the salts and polymorphs in the treatment of protein kinase related disorders.
    Type: Grant
    Filed: February 6, 2012
    Date of Patent: March 24, 2015
    Assignee: Zoetis LLC
    Inventors: Changquan C. Sun, Michael Hawley
  • Publication number: 20120142749
    Abstract: The present invention relates to solid salt forms of the 3-pyrrole substituted 2-indolinone compound 5-[5-fluoro-2-oxo-1, 2-dihydro-indol-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-pirrolidin-1-yl-ethyl)-amide. It also relates to polymorphs of the phosphate salt of the amide. The invention further relates to the use of the salts and polymorphs in the treatment of protein kinase related disorders.
    Type: Application
    Filed: February 6, 2012
    Publication date: June 7, 2012
    Applicants: PFIZER PRODUCTS INC., PFIZER INC.
    Inventors: Changquan C. Sun, Michael Hawley
  • Patent number: 7794191
    Abstract: In a method for producing large-scale pages of a book, one or a plurality of long sheets of paper or other flexible material is folded in an alternative forward and reverse direction along a single axis, yielding an accordion fold structure. Such pages are bound along a single edge to yield a book of enormous proportion. According to one exemplary embodiment, each page of the book is of approximately five feet by seven feet in dimension, yielding a compelling visual display that may contain life-sized portraits, brilliant landscapes, detailed maps, a panoply of disparate visual images, text, diagrams, or blank pages for creative uses. Methods of binding may include tabbing folds of the pages and then stitching through the tabs.
    Type: Grant
    Filed: December 15, 2004
    Date of Patent: September 14, 2010
    Inventors: Michael Hawley, Paul A. Parisi, Wladyslaw Hanower, Pam Hanower, legal representative, Pete Merrill-Oldham
  • Patent number: 7572924
    Abstract: The present invention relates to pyrrole substituted-2-indolinone compounds and their pharmaceutically acceptable salts which modulate the activity of protein kinases and therefore are expected to be useful in the prevention and treatment of protein kinase related cellular disorders such as cancer.
    Type: Grant
    Filed: September 6, 2006
    Date of Patent: August 11, 2009
    Assignees: Sugen, Inc., Pharmacia & Upjohn Co.
    Inventors: Peng Cho Tang, Todd Anthony Miller, Xiaoyuan Li, Connie Li Sun, Chung Chen Wei, Shahrzad Shirazian, Congxin Liang, Tomas Vojkovsky, Asaad S. Nematalla, Michael Hawley
  • Publication number: 20090048327
    Abstract: The present invention relates to polymorphs of the 3-pyrrole substituted 2-indolinone compound 5-(5-fluoro-2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-pyrrolidin-1-yl-ethyl)-amide.
    Type: Application
    Filed: October 13, 2008
    Publication date: February 19, 2009
    Applicant: PHARMACIA & UPJOHN COMPANY
    Inventors: Changquan Sun, Todd P Foster, Fusen Han, Michael Hawley, Tom Thamann
  • Patent number: 7452913
    Abstract: The present invention relates to polymorphs of the 3-pyrrole substituted 2-indolinone compound 5-(5-fluoro-2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-pyrrolidin-1-yl-ethyl)-amide.
    Type: Grant
    Filed: February 12, 2004
    Date of Patent: November 18, 2008
    Assignee: Pharmacia & Upjohn Company
    Inventors: Changquan Sun, Todd P. Foster, Fusen Han, Michael Hawley, Tom Thamann
  • Publication number: 20080275101
    Abstract: The present invention relates to solid salt forms of the 3-pyrrole substituted 2-indolinone compound 5-[5-fluoro-2-oxo-1,2-dihydro-indol-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-pyrrolidin-1-yl-ethyl)-amide. It also relates to polymorphs of the phosphate salt of the amide. The invention further relates to the use of the salts and polymorphs in the treatment of protein kinase related disorders.
    Type: Application
    Filed: September 8, 2006
    Publication date: November 6, 2008
    Applicants: PFIZER INC., PFIZER PRODUCTS INC.
    Inventors: Michael Hawley, Changquan C. Sun
  • Patent number: 7439397
    Abstract: The compound 2-[(1R)-3-(diisopropylamino)-1-phenylpropyl]-4-(trifluoromethyl) phenol may be used to prepare the compound (3R)-3-[2-hydroxy-5-(trifluoromethyl)phenyl]-N,N-diisopropyl-N-methyl-3-phenylpropan-1-aminium bromide by reaction with methyl bromide.
    Type: Grant
    Filed: March 8, 2005
    Date of Patent: October 21, 2008
    Assignee: Pfizer Inc
    Inventors: Ivan Richards, Sue K. Cammarata, Craig D. Wegner, Michael Hawley, Mark Peter Warchol, Mark Kontny, Walter Morozowich, Karen Patrice Kolbasa, Malcolm Wilson Moon, Dominique Bonafoux, Sergey Gregory Wolfson, Patrick James Lennon
  • Patent number: 7435832
    Abstract: The present invention provides crystals, and compositions thereof, wherein the crystals include a malic acid salt of N-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide. Methods of preparing such crystals are also disclosed.
    Type: Grant
    Filed: April 26, 2007
    Date of Patent: October 14, 2008
    Assignee: Pharmacia & Upjohn Company
    Inventors: Michael Hawley, Thomas J. Fleck, Stephen P. Prescott, Mark T. Maloney
  • Publication number: 20070191458
    Abstract: The present invention provides crystals, and compositions thereof, wherein the crystals include a malic acid salt of N-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide. Methods of preparing such crystals are also disclosed.
    Type: Application
    Filed: April 26, 2007
    Publication date: August 16, 2007
    Inventors: Michael Hawley, Thomas Fleck, Stephen Prescott, Mark Maloney
  • Publication number: 20070010569
    Abstract: The present invention relates to pyrrole substituted-2-indolinone compounds and their pharmaceutically acceptable salts which modulate the activity of protein kinases and therefore are expected to be useful in the prevention and treatment of protein kinase related cellular disorders such as cancer.
    Type: Application
    Filed: September 6, 2006
    Publication date: January 11, 2007
    Inventors: Peng Tang, Todd Miller, Xiaoyuan Li, Li Sun, Chung Wei, Shahrzad Shirazian, Congxin Liang, Tomas Vojkovsky, Asaad Nematalla, Michael Hawley
  • Patent number: 7125905
    Abstract: The present invention relates to pyrrole substituted 2-indolinone compounds and their pharmaceutically acceptable salts which modulate the activity of protein kinases and therefore are expected to be useful in the prevention and treatment of protein kinase related cellular disorders such as cancer.
    Type: Grant
    Filed: January 4, 2005
    Date of Patent: October 24, 2006
    Assignee: Agouron Pharmaceuticals, Inc.
    Inventors: Peng Cho Tang, Todd A. Miller, Xiaoyuan Li, Li Sun, Chung Chen Wei, Shahrzad Shirazian, Congxin Liang, Tomas Vojkovsky, Asaad S. Nematalla, Michael Hawley
  • Patent number: 7005449
    Abstract: The present invention concerns novel pharmaceutically active compounds, pharmaceutical compositions containing the same, the compounds for use as medicaments, and use of the compounds for the manufacture of specific medicaments. The present invention also concerns a method of treatment involving administration of the compounds. Specifically, the compounds are pharmaceutically acceptable salts of tolterodine or hydroxytolterodine, wherein the salt is of an acid selected from the group consisting of aliphatic mono- and dicarboxylic acids comprising from 7 to 24 carbon atoms, alkanedisulfonic acids comprising from 2 to 4 carbon atoms, naphthoic acid derivatives comprising from 11 to 27 carbon atoms, maleic acid and fumaric acid.
    Type: Grant
    Filed: April 23, 2002
    Date of Patent: February 28, 2006
    Assignee: Pharmacia & Upjohn Company
    Inventors: Michael Hawley, Satish Kumar Singh, Walter Morozowich, Mark P. Warchol
  • Publication number: 20050276678
    Abstract: In a method for producing large-scale pages of a book, one or a plurality of long sheets of paper or other flexible material is folded in an alternative forward and reverse direction along a single axis, yielding an accordion fold structure. Such pages are bound along a single edge to yield a book of enormous proportion. According to one exemplary embodiment, each page of the book is of approximately five feet by seven feet in dimension, yielding a compelling visual display that may contain life-sized portraits, brilliant landscapes, detailed maps, a panoply of disparate visual images, text, diagrams, or blank pages for creative uses. Methods of binding may include tabbing folds of the pages and then stitching through the tabs.
    Type: Application
    Filed: December 15, 2004
    Publication date: December 15, 2005
    Inventors: Michael Hawley, Paul Parisi, Wladyslaw Hanower, Pete Merrill-Oldham, Pam Hanower
  • Publication number: 20050192236
    Abstract: The antibiotic drug clindamycin is provided as a crystalline free base. Three polymorphic/pseudopolymorphic forms of crystalline clindamycin free base are disclosed. Also provided are pharmaceutical compositions comprising crystalline clindamycin free base. Processes for preparing crystalline clindamycin free base and compositions thereof are also provided along with methods for treating medical conditions with the pharmaceutical compositions.
    Type: Application
    Filed: May 2, 2005
    Publication date: September 1, 2005
    Inventors: Robert Chao, Michael Hawley, Lisa Reeder, Donald Jones
  • Publication number: 20050176802
    Abstract: The present invention relates to pyrrole substituted 2-indolinone compounds and their pharmaceutically acceptable salts which modulate the activity of protein kinases and therefore are expected to be useful in the prevention and treatment of protein kinase related cellular disorders such as cancer.
    Type: Application
    Filed: January 4, 2005
    Publication date: August 11, 2005
    Inventors: Peng Cho Tang, Todd Miller, Xiaoyuan Li, Li Sun, Chung Chen Wei, Shahrzad Shirazian, Congxin Liang, Tomas Vojkovsky, Asaad Nematalla, Michael Hawley